English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO

    business

    Bull vs Bear: What's the outlook on Sun Pharma?

    Sun Pharma is the biggest loser on the Nifty as it missed estimates. Also, the management gave a very conservative guidance of 8-10 percent growth in consolidated sales for FY17. A bullish SP Tulsian of sptulsian.com gave a support price of Rs 700.

    first published: May 31, 2016 03:47 pm

    LATEST VIDEOS

    Watch More →

    A collection of the most-viewed Moneycontrol videos.

    Watch and Follow our leading shows